Charles Schwab Investment Management Inc. Has $179.65 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)

Charles Schwab Investment Management Inc. boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 3.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,519,011 shares of the company’s stock after buying an additional 44,386 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.63% of Cardinal Health worth $179,653,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CAH. Frazier Financial Advisors LLC increased its holdings in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after acquiring an additional 104 shares during the last quarter. Hara Capital LLC acquired a new position in Cardinal Health during the third quarter valued at approximately $31,000. AM Squared Ltd acquired a new position in Cardinal Health during the third quarter valued at approximately $33,000. Kentucky Trust Co bought a new position in shares of Cardinal Health in the fourth quarter valued at approximately $41,000. Finally, HHM Wealth Advisors LLC lifted its stake in shares of Cardinal Health by 57.6% in the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock worth $47,000 after buying an additional 144 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Performance

Shares of CAH stock opened at $126.72 on Friday. The firm has a fifty day moving average of $125.28 and a 200-day moving average of $118.57. The stock has a market cap of $30.61 billion, a price-to-earnings ratio of 23.64, a P/E/G ratio of 1.49 and a beta of 0.63. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is 37.69%.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Citigroup lifted their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. Argus set a $148.00 price objective on Cardinal Health in a research note on Tuesday, February 4th. JPMorgan Chase & Co. increased their target price on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Morgan Stanley raised their target price on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a report on Friday, January 31st. Finally, Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and upped their price target for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.